Loading…
Back To Schedule
Tuesday, June 16 • 8:00am - 9:00am
#205 SL: Using Artificial Intelligence to Inform Regulatory and Development Strategies

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Tweet Share
Component Type: Session
Level: Intermediate
CE: ACPE 1.00 Knowledge UAN: 0286-0000-20-565-L04-P; CME 1.00; IACET 1.00; RN 1.00

Artificial intelligence and data science can help increase the efficiency of drug development. We will explore how pharma companies and researchers are leveraging artificial intelligence to identify insights and make predictions about regulatory strategies and drug development, and what is needed for further adoption.

Learning Objectives

Describe how artificial intelligence is being applied in the pharmaceutical industry to inform decisions about regulatory strategies and drug development; Discuss what is needed to enable further use of artificial intelligence to support decision making.

Chair

Nicholas Drago, MS, RAC

Speaker

Can Artificial Intelligence Inform Regulatory Strategy?
Andrew Robertson, JD, PhD

Estimating and Predicting the Probabilities of Success of Clinical Trials: A Data Science Perspective
Andrew Lo, PhD, MA, MBA, PMP


Speakers
avatar for Andrew Robertson

Andrew Robertson

Global Head of Strategy, and Business Transformation, Digital and Data Sciences, Sanofi
Andrew Robertson is the Global Head of Strategy and Transformation for Sanofi-R&D Digital & Data Sciences. Andrew has more than 14 years of collective experience working in life sciences, policy and law, and has authored multiple peer-reviewed articles on topics pertaining to health... Read More →
avatar for Nicholas Drago

Nicholas Drago

Associate Director, Global Regulatory Strategy, Bayer, United States
Nicholas Drago is Associate Director of Global Regulatory Strategy at Bayer Pharmaceuticals. Previously, he led Bayer’s global regulatory policy efforts for cell & gene therapy and spearheaded the application of data science to support decision making in regulatory affairs. Nicholas... Read More →
avatar for Andrew Lo

Andrew Lo

Charles E. and Susan T. Harris Professor of Finance, Sloan School of Management, Massachusetts Institute of Technology (MIT)
Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of MIT’s Laboratory for Financial Engineering, and principal investigator at MIT's Computer Science and Artificial Intelligence Laboratory. His research interests include... Read More →

Tuesday June 16, 2020 8:00am - 9:00am EDT
TBD Virtual Event Horsham, PA 19044
  09: Regulatory, Session